Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Strong Sell

Price to Earnings Rating

Strong Sell

Analyst Rating

Strong Sell

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Neutral

Standard Deviation

Sell

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Sell

C

Biodesix, Inc. Common Stock (BDSX)

Services-medical Laboratories

https://www.biodesix.com

Biodesix Inc is a data-driven diagnostic solutions company. Its artificial intelligence-based platform helps to discover, develop, and commercialize solutions for clinical unmet needs, with a focus on lung disease. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

2970 WILDERNESS PLACE, SUITE 100
BOULDER, CO

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

10/28/2020

Market Cap

256,237,405

Shares Outstanding

90,480,000

Weighted SO

90,476,295

Total Employees

N/A

Upcoming Earnings

08/05/2024

Similar Tickers

GTH --.--%

ACRS --.--%

CSTL --.--%

PRE --.--%

DRIO --.--%

OLK --.--%

XGN --.--%

STIM --.--%

FONR --.--%

Beta

1.2010

Last Div

0.0000

Range

1.15-2.21

Chg

0.0300

Avg Vol

142485

Mkt Cap

256237405

Exch

NASDAQ

Country

US

Phone

303 417 0500

DCF Diff

N/A

DCF

0.0000

Div Yield

0.0000

P/S

4.2074

EV Multiple

-9.4386

P/FV

6.1901

Div Yield %

0.0000

P/E

-5.0427

PEG

-0.1944

Payout

0.0000

Current Ratio

3.2805

Quick Ratio

3.2121

Cash Ratio

2.4111

DSO

60.6995

DIO

32.0762

Op Cycle

92.7756

DPO

59.3409

CCC

33.4347

Gross Margin

0.7758

Op Margin

-0.5442

Pretax Margin

-0.7308

Net Margin

-0.7308

Eff Tax Rate

-0.0097

ROA

-0.3842

ROE

-5.2532

ROCE

-0.3372

NI/EBT

1.0000

EBT/EBIT

1.3430

EBIT/Rev

-0.5442

Debt Ratio

0.3120

D/E

0.9968

LT Debt/Cap

0.4969

Total Debt/Cap

0.4992

Int Coverage

-6.2436

CF/Debt

-1.3614

Equity Multi

3.1947

Rec Turnover

6.0132

Pay Turnover

6.1509

Inv Turnover

11.3792

FA Turnover

2.0447

Asset Turnover

0.5257

OCF/Share

-0.3869

FCF/Share

-0.4747

Cash/Share

0.3328

OCF/Sales

-0.8080

FCF/OCF

1.2267

CF Coverage

-1.3614

ST Coverage

-146.0148

CapEx Coverage

-4.4116

Div&CapEx Cov

-4.4116

P/BV

6.1901

P/B

6.1901

P/S

4.2074

P/E

-5.0427

P/FCF

-4.2451

P/OCF

-4.5614

P/CF

-4.5614

PEG

-0.1944

P/S

4.2074

EV Multiple

-9.4386

P/FV

6.1901

DPS

0.0000

Latest Headlines (EST)

Zacks Investment Research Dec 26, 11:45 3 Reasons to Retain Nevro (NVRO) in Your Portfolio for Now Zacks Investment Research Dec 08, 14:15 BD's (BDX) Novel Blood Collection System MiniDraw Gets FDA Nod Zacks Investment Research Dec 08, 14:11 Cooper Companies (COO) Q4 Earnings In Line, '23 Outlook Raised

Revenue Product Segmentation